Positive CHMP recommendation for antibiotic combination
EMA has recommended granting a marketing authorisation for Emblaveo for treatment of infections caused by multidrug-resistant bacteria.
List view / Grid view
EMA has recommended granting a marketing authorisation for Emblaveo for treatment of infections caused by multidrug-resistant bacteria.
Researchers have found that a novel combination of antibiotics that was able to kill E. coli carrying mcr-1 and ndm-5 genes within 24 hours...